Skip to main content
. 2020 May 29;10(6):354. doi: 10.3390/diagnostics10060354

Figure 2.

Figure 2

Characteristic changes observed in MRI types 1 and 2 of Fazekas stage 3 cerebral small vessel disease (cSVD) on FLAIR (highlighted with a white square) and axial susceptibility weighted imaging sequence (SWI) MRI slices.